Header Logo

Connection

Paul Thompson to Neoplasms

Back to Details
This is a "connection" page, showing publications Paul Thompson has written about Neoplasms.
Paul Thompson
Connection Strength
0.366
Neoplasms
  1. Slack JL, Causey CP, Thompson PR. Protein arginine deiminase 4: a target for an epigenetic cancer therapy. Cell Mol Life Sci. 2011 Feb; 68(4):709-20.
    View in: PubMed
    Score: 0.162
  2. Mondal S, Thompson PR. Chemical biology of protein citrullination by the protein A arginine deiminases. Curr Opin Chem Biol. 2021 08; 63:19-27.
    View in: PubMed
    Score: 0.084
  3. Bicker KL, Thompson PR. The protein arginine deiminases: Structure, function, inhibition, and disease. Biopolymers. 2013 Feb; 99(2):155-63.
    View in: PubMed
    Score: 0.048
  4. Jones JE, Causey CP, Knuckley B, Slack-Noyes JL, Thompson PR. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. Curr Opin Drug Discov Devel. 2009 Sep; 12(5):616-27.
    View in: PubMed
    Score: 0.038
  5. Zou Y, Broughton DL, Bicker KL, Thompson PR, Lavigne JJ. Peptide borono lectins (PBLs): a new tool for glycomics and cancer diagnostics. Chembiochem. 2007 Nov 23; 8(17):2048-51.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.